Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Chromadex Corp CDXC

Technology Scientific & Technical Instruments
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CDXC)

ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement

Business Wire 10 days ago

ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide

Business Wire November 7, 2024

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

Business Wire October 31, 2024

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

Business Wire October 28, 2024

ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

Business Wire October 24, 2024

ChromaDex to Participate in the 17th Annual LD Micro Main Event

Business Wire October 23, 2024

Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)

Business Wire October 15, 2024

ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference

Business Wire September 26, 2024

ChromaDex Appoints Ozan Pamir as Chief Financial Officer

Business Wire September 20, 2024
View More News ››

Opinion & Analysis (NDAQ:CDXC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CDXC)

ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designatio

Just In: $CDXC ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for...
whytestocks - June 7, 2024

Nice coverage and valuation article on Chromadex

ChromaDex: Blazing Ahead Of Ponce De Leon (NASDAQ:CDXC) | Seeking Alpha seekingalpha.com/article/4378493-chromadex-blazing-ahead-of...
jthottam - December 20, 2020

Keeping people as young and healthy as possible

sounds like a pretty good thing. Bought first shares today
scopro - May 3, 2019

This one has me fustrated.

I love the product. I use the product. But the stock is killing me. When it ran to 6 bucks. I thought, here we go. On our way to 20...
HERO547 - January 15, 2017

This report will be the game changer.

ChromaDex to Report First Quarter 2016 Financial Results on Thursday, May 12, 2016 Company Will Host Investor Conference Call on...
HERO547 - May 10, 2016

We be ringing the bell.

https://finance.yahoo.com/news/chromadex-corp-nasdaq-cdxc-ring-140000216.html
HERO547 - May 5, 2016
View more Bullboard ››

Leading Edge Materials Corp.

Leading Edge Materials Corp.

Leading Edge Materials Corp. is a Canada-based company focused on developing a portfolio of critical raw material projects ...
View More »